phospholamban Inhibitors

Phospholamban inhibitors comprise a group of chemicals that either directly or indirectly modulate the activity of phospholamban, a key regulator of calcium transport in cardiac cells. While there are limited direct inhibitors identified for phospholamban, several chemicals indirectly impact its function by influencing various signaling pathways involved in calcium handling. KN-93 and AIP (Autoinhibitory Peptide) are inhibitors of CaMKII, indirectly modulating phospholamban. By preventing CaMKII activation, these compounds disrupt the phosphorylation of phospholamban, leading to altered calcium handling in cardiac cells and influencing contractility. Thapsigargin inhibits SERCA, indirectly impacting phospholamban. By blocking SERCA, Thapsigargin disrupts calcium reuptake into the sarcoplasmic reticulum, leading to increased cytoplasmic calcium levels and altered phospholamban activity in regulating calcium transport. Rostafuroxin inhibits Na+/K+-ATPase, indirectly affecting phospholamban. By modulating sodium and potassium transport, Rostafuroxin influences intracellular sodium levels, which can impact calcium handling and phospholamban activity in cardiac cells.

Calmidazolium inhibits calmodulin, indirectly influencing phospholamban. By blocking calmodulin, Calmidazolium disrupts the activation of CaMKII, which phosphorylates phospholamban, leading to altered calcium handling in cardiac cells and impacting contractility. CGP-37157 and CGP-60474 are inhibitors that indirectly modulate phospholamban. CGP-37157 affects mitochondrial calcium levels, influencing cytoplasmic calcium dynamics, while CGP-60474 blocks PKA, disrupting the phosphorylation of phospholamban and impacting calcium handling in cardiac cells. W-7 inhibits calmodulin, indirectly affecting phospholamban. By blocking calmodulin, W-7 disrupts the activation of CaMKII, which phosphorylates phospholamban, leading to altered calcium handling in cardiac cells and impacting contractility. Ryanodine inhibits ryanodine receptors (RyR), indirectly influencing phospholamban. By modulating RyR activity, Ryanodine affects calcium release from the sarcoplasmic reticulum, leading to altered calcium dynamics and modulation of phospholamban function in regulating calcium transport.